Gazyva 100 mg Injection
4,525.22$
3,831.05$
Gazyva 100 mg injection is an innovative immunotherapy designed to target and treat chronic lymphocytic leukemia (CLL) and follicular lymphoma, both of which impact the body's immune system by affecting B lymphocytes. This medication can be administered as a standalone treatment or alongside other therapies to enhance its efficacy against these specific cancers. By utilizing a targeted mechanism that inhibits the growth of cancerous cells, Gazyva helps to improve patient outcomes and manage disease progression effectively. It's essential for patients to discuss their complete medical history with their healthcare provider, as Gazyva may carry risks such as increased susceptibility to infections due to its immunosuppressive effects. Additionally, regular monitoring is advised during treatment to identify any potential adverse reactions. With a professional approach to cancer care, Gazyva offers hope to those diagnosed with these challenging conditions. Always consult your healthcare professional before starting any new treatment to ensure it's the right choice for your individual health needs.
الكمية
Active Pharmaceutical Ingredient
Uses
• Gazyva 100 mg injection is primarily indicated for the treatment of chronic lymphocytic leukemia (CLL). This type of blood cancer affects the lymphocytes, which are crucial components of the immune system. By using Gazyva, healthcare providers can help manage the disease effectively, especially in patients who may require additional therapies. The medication works by targeting specific proteins on the cancer cells, aiding in their destruction.
• In addition to CLL, Gazyva 100 mg injection is also utilized for the treatment of follicular lymphoma. This slow-growing non-Hodgkin lymphoma often arises from B-lymphocytes in the lymph nodes. Gazyva helps to control the proliferation of these cancerous cells, which may remain asymptomatic for extended periods. When symptoms do manifest, Gazyva can provide significant therapeutic benefits in alleviating them.
• Gazyva 100 mg injection can be administered alone or in combination with other treatments to enhance patient outcomes. This flexibility allows oncologists to tailor therapy based on individual patient needs and disease characteristics. The use of Gazyva in combination therapy can lead to improved response rates in certain patient populations. It plays a vital role in the comprehensive management of lymphoid malignancies.
• The application of Gazyva 100 mg injection is crucial in cases where patients have relapsed or refractory forms of CLL or follicular lymphoma. For these patients, traditional therapies may have become less effective, making Gazyva an essential option in their treatment plan. The medication not only targets the cancer cells but also supports the immune system's ability to fight the disease. This dual action can result in better disease control and improved quality of life for patients.
Benefits
Obinutuzumab Injection 100 mg is used to treat certain types of cancer, including chronic lymphocytic leukemia (CLL) and follicular lymphoma. Chronic Lymphocytic Leukemia (CLL) is a type of cancer that affects the blood and bone marrow. It is a slow-growing cancer that arises from abnormal white blood cells called lymphocytes. Gazyva 100 mg may be used with other medicines that may delay the disease progression and improve the survival rates. Follicular lymphoma is a type of non-Hodgkin lymphoma (NHL) that arises from B-lymphocytes in the lymph nodes. Gazyva 100 mg Vial is an immunosuppressive medicine that works by targeting and destroying cancerous cells in the body.
Side Effects
As with all medicines, Anti-cancer Drug Gazyva may cause side effects that do not require medical attention and that will disappear as your body adjusts to the medicine. If they persist or you're concerned about them, talk to your doctor.
Most Common Side Effects
• Injection site reactions
• Muscle or joint pain
• Stuffy nose
• Sneezing
• Cough
• Sore throat
Common Side Effects
• Tiredness
• Low white blood cell counts
• Diarrhoea
• Constipation
How To Use
Gazyva 100 mg Vial is given as an infusion, which is a slow injection into a vein over some time. The infusion is given by a doctor or nurse in a hospital or clinic. Your doctor will decide when it's right for you to have the infusion, so always follow your doctor's advice—the dose and how often you have it will depend on what you're taking it for. You may also be prescribed certain other medicines as part of your treatment. You will need to take this medicine for as long as it's prescribed for you.
Safety Advice
• Alcohol: Consumption of alcohol is not recommended while using Gazyva 100 mg. Alcohol may increase or decrease the effectiveness of the medicine and also increase the risk of side effects. It is the best advice for you: before consuming alcohol, you can talk with a doctor or pharmacist, and they will tell you if consumption of alcohol is safe or not.
• Kidney: Patients with kidney disease should use caution when taking Gazyva 100 mg Vial. It is important for people with kidney problems to monitor their kidney function closely while using Obinutuzumab Injection 100 mg and to inform their doctor immediately of any abnormal symptoms or changes in kidney function. Dosage adjustments may be required in these patients under the guidance of a healthcare professional.
• Breastfeeding: It is not recommended to breastfeed while taking Gazyva 100 mg Vial. It is possible that Gazyva 100 mg may pass into breast milk and harm the baby. If you are breastfeeding and taking Anti-cancer Drug Gazyva, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make a satisfactory choice for you and your baby's health.
• Liver: People with liver disease should use Gazyva Injection with caution. It is important for people with liver disease to monitor their liver function regularly while using Gazyva 100 mg and to tell their doctor immediately of any abnormal symptoms or changes in liver function. Dose adjustments may be necessary in patients with liver disease.
• Pregnancy: It is advisable to avoid using Gazyva Injection during pregnancy, as evidence from animal studies suggests potential harm to the developing fetus. However, if you are currently pregnant or considering becoming pregnant, it is important to discuss the potential benefits and risks of taking Gazyva 100 mg Injection during pregnancy with your doctor. Your doctor will be able to guide you to help you make an informed decision that prioritises the wellbeing of both you and your baby.
• Driving: Gazyva 100 mg Injection is not expected to have an impact on your driving skills or ability to operate machinery. However, if you encounter any side effects like dizziness or drowsiness while using Gazyva 100 mg, it is crucial to refrain from driving or operating heavy machinery until these side effects have subsided.